register

News & Trends - MedTech & Diagnostics

APHA CEO bids farewell after 24 years of leadership and advocacy

Health Industry Hub | April 17, 2024 |

MedTech & Diagnostics News: Michael Roff, CEO of the Australian Private Hospitals Association (APHA), has announced his resignation from the position, effective 5 July, 2024.

Over the span of 30 years, Mr Roff has been an integral part of the association, initially joining as the Public Affairs Manager in 1994 before assuming the role of CEO in March 2000. Throughout his tenure, he has been a stalwart advocate for the private hospitals sector, engaging with nine different Federal Health Ministers and eight Prime Ministers on its behalf.

“I have spent half my life and the majority of my professional life with APHA and it has been an honour to
represent a sector committed to providing the highest quality health services to millions of Australians each year,” Mr Roff said.

He further added, “It has been stimulating to work at the intersection of healthcare delivery, policy and politics, and the sector has faced many challenges over the years, not least the COVID-19 pandemic when elective surgery was shut down overnight. However, after 24 years as CEO it is time to move on.

“I want to thank my staff who work tirelessly every day to support the private hospitals sector, the APHA
Board who volunteer their time and expertise for the greater good of the sector and our member hospitals for their support over many years.”

APHA President Christine Gee AM expressed the challenge of encapsulating Mr Roff’s significant contributions to the private hospital sector in just a few paragraphs.

“I have had the good fortune and great pleasure to work with Michael over many years, a number of those as President of APHA. I am sure that the management of our Association could not have been in safer or more capable hands especially over the last few very tumultuous years. He can be very proud of his efforts and achievements for and on behalf of Australia’s private hospital system and the healthcare system more broadly.

“Michael is a highly respected advocate and a consummate professional who has dedicated his skills and
expertise to representing Australia’s private hospitals with the firm focus of ensuring our sector remains in
the best position to provide vital and necessary services to the Australian community,” she expressed.

As the Board commences the search for APHA’s next CEO, Mr Roff’s willingness to assist in the transition on a part-time basis reflects his ongoing dedication to the association’s success.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


Medical

NSW Health to settle class action

NSW Health to settle ‘largest’ class action

Health Industry Hub | April 29, 2024 |

A class action alleging NSW Health underpaid clinicians has settled after the department agreed to a payout of nearly a […]

More


News & Trends - Pharmaceuticals

Lilly's first-in-class therapy PBS listed for early breast cancer after 15-year gap

Lilly’s first-in-class therapy PBS listed for early breast cancer after 15-year gap

Health Industry Hub | April 29, 2024 |

Pharma News: Australians diagnosed with early-stage breast cancer, particularly those at high risk of recurrence, will gain access to the […]

More


News & Trends - Pharmaceuticals

AstraZeneza secures four PBAC nods in oncology, diabetes, kidney and rare diseases

AstraZeneza secures four PBAC nods in oncology, diabetes, kidney and rare diseases

Health Industry Hub | April 29, 2024 |

Pharma News: AstraZeneca has scored four positive Pharmaceutical Benefits Advisory Committee (PBAC) recommendations following the March meeting. These recommendations, spanning […]

More


News & Trends - Pharmaceuticals

PBAC recommendation to reshape prescribing in heart failure

PBAC recommendation to reshape prescribing in heart failure

Health Industry Hub | April 29, 2024 |

Pharma News: Aligned with the government’s Scope of Practice Review, the Pharmaceutical Benefits Advisory Committee (PBAC) has made a practice-changing […]

More


This content is copyright protected. Please subscribe to gain access.